Dietary supplementation may improve antibiotic-induced GVHD following stem cell transplants
Researchers at Âé¶¹Ó³» MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after antibiotic treatment of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and discovered that nutritional supplementation can prevent antibiotic-induced GVHD in preclinical models, according to a study published today in Cell.
Researchers led...

MD Anderson Research Highlights for September 28, 2022
Âé¶¹Ó³» MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer...
MD Anderson celebrates World Cancer Research Day
Âé¶¹Ó³»Â MD Anderson Cancer Center again supports World Cancer Research Day, Sept. 24, and its goals to highlight...
MD Anderson Research Highlights for September 14, 2022
Âé¶¹Ó³» MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a new targeted therapy for small cell lung cancer, a potential combination therapy for gastric cancer, recommendations for post-surgical colonoscopies for colorectal cancer, a link between coffee consumption and survival in prostate...

MD Anderson Research Highlights: ESMO 2022 Special Edition
ABSTRACTS 735MO, 316O, 1MO, 1493MO, 457MO, 283MO, LBA68, 785O  Â
The University of...
Swathi Arur named Emerging Leader in Health and Medicine Scholar by National Academy of Medicine
Swathi Arur, Ph.D., professor and deputy chair of Genetics at Âé¶¹Ó³» MD Anderson Cancer Center, has been selected as one...